Actuate Therapeutics ACTU Cash Flow Statement (2023-2026)

NASDAQ ACTU
$0.31 0.00 (-0.66%)
As of: Nov 10, 2026 · 12:08 PM EST
Reported Financials

Actuate Therapeutics Quarterly Cash Flow Statement

Periods 13 quarters
Latest Jun 2026

Actuate Therapeutics reported cash from operations of -$4.41M and free cash flow of -$4.41M for the quarter ended Jun 2026, down 5.5% year over year. This cash flow statement covers 13 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -5.52M-6.34M-7.61M-8.30M-6.57M-5.97M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Share-based CompensationStock Comp. 0.07M0.16M0.12M0.15M0.09M0.57M1.19M1.13M1.58M1.80M1.54M1.34M
Other non-cash itemsOther Non-Cash 0.05M-0.02M0.05M0.03M0.24M-0.19M
Change in Working Capital
Change in Account PayablesChange Payables 0.22M0.86M0.48M1.93M-3.61M-0.30M0.62M0.51M-1.83M0.19M-0.32M-0.15M
Change in Accrued ExpensesChange Accrued Exp. 0.48M0.79M1.96M0.81M0.10M-0.17M-0.72M-0.63M-0.31M-0.69M-0.96M-0.30M
Change in Other Operating AssetsOther Assets Change 0.00M0.01M0.08M0.08M0.54M-0.06M-0.32M-0.16M0.32M-0.04M-0.10M-0.06M
Other Working Capital ChangesOther WC Changes 0.00M-0.01M-0.08M-0.08M-0.54M0.06M0.32M0.16M-0.32M0.04M0.10M0.06M
Cash from OperationsCash from Ops. -5.64M-5.51M-5.25M-2.67M-9.15M-4.77M-4.62M-4.17M-6.68M-3.74M-5.02M-4.41M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 4.50M1.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt 4.50M1.00M
Net Debt Issuances and RepaymentsNet Debt Issuance 4.50M1.00M
Change in Capital Stock
Common Stock IssuedStock Issued 23.96M1.63M0.52M0.73M
Shares Repurchased 0.11M
Net Shares Issued and RepurchasedNet Shares Issued 23.96M-0.11M1.63M0.52M0.73M
Net Equity Issued and RepurchasedNet Equity Issued 23.96M-0.11M1.63M0.52M0.73M
Other financing activities (as filed) -0.14M-0.04M0.19M-0.13M-0.04M-0.10M-0.03M-0.03M
Cash from Financing ActivitiesCash from Financing 4.36M0.96M22.32M-0.11M-0.13M6.78M17.11M-0.03M-0.01M0.70M
Additional items
Change in Cash -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M-5.03M-3.71M
Ending Cash Balance 14.11M8.47M2.96M2.07M0.35M13.52M8.64M3.89M6.49M16.92M13.16M4.43M
Free Cash FlowFCF -5.64M-5.51M-5.25M-2.67M-9.15M-4.77M-4.62M-4.17M-6.68M-3.74M-5.02M-4.41M
Net Cash FlowNCF -5.64M-5.51M-0.89M-1.72M13.17M-4.88M-4.75M2.60M10.43M-3.77M-5.03M-3.71M
Interest Paid 0.07M0.07M
Income Taxes PaidTaxes Paid 800.00800.00800.00

Actuate Therapeutics Cash Flow Statement API

Pull Actuate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACTU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY